Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
773
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States
Deborah R. Kayea Duke University Cancer Center, Durham, NC, USAView further author information
, Ibrahim Khilfehb Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USAView further author information
, Erik Muserb Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USAView further author information
, Laura Morrisonc Analysis Group, Inc, Montréal, QC, CanadaView further author information
, Frederic Kinkeadc Analysis Group, Inc, Montréal, QC, CanadaView further author information
, Patrick Lefebvrec Analysis Group, Inc, Montréal, QC, CanadaView further author information
, Dominic Pilonc Analysis Group, Inc, Montréal, QC, CanadaCorrespondence[email protected]
View further author information
& View further author information
Daniel Georgea Duke University Cancer Center, Durham, NC, USAView further author information
show all
Pages 381-391
|
Received 10 Jan 2024, Accepted 23 Feb 2024, Published online: 11 Mar 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.